Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025)
Roivant Sciences (ROIV) reported Interest & Investment Income of $43.3 million for Q4 2025, down 30.05% on a YoY basis from $61.9 million in Q4 2024, and down 4.58% quarter-over-quarter from $45.3 million in Q3 2025.
Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025) Analysis & Trends
Roivant Sciences has reported Interest & Investment Income for 5 years, with the latest figure at $43.3 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 30.05% year-over-year to $43.3 million; the trailing twelve-month figure through Dec 2025 stood at $198.8 million (down 15.67% YoY), and the FY2026 full-year result was $178.1 million, down 31.07% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $43.3 million, down from $45.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $72.1 million in Q2 2024, with the low at $62000.0 in Q3 2021.
- Historically, Interest & Investment Income has averaged $30.1 million across 5 years, with a median of $24.3 million in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 15428.79% — and 2025, when it tumbled 35.02%.
- Roivant Sciences' Interest & Investment Income stood at $66000.0 in 2021, then jumped by 15428.79% to $10.2 million in 2022, then soared by 211.77% to $32.0 million in 2023, then soared by 93.57% to $61.9 million in 2024, then sank by 30.05% to $43.3 million in 2025.
- The last three Interest & Investment Income figures came in at $43.3 million (Q4 2025), $45.3 million (Q3 2025), and $48.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.27 Mn |
| Sep 30, 2025 | 45.34 Mn |
| Jun 30, 2025 | 48.32 Mn |
| Dec 31, 2024 | 61.85 Mn |
| Sep 30, 2024 | 69.77 Mn |
| Jun 30, 2024 | 72.13 Mn |
| Dec 31, 2023 | 31.95 Mn |
| Sep 30, 2023 | 14.30 Mn |
| Jun 30, 2023 | 16.72 Mn |
| Dec 31, 2022 | 10.25 Mn |
| Sep 30, 2022 | 5.67 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Dec 31, 2021 | 66,000.00 |
| Sep 30, 2021 | 62,000.00 |